Localized SDF-1 mRNA nanoparticle delivery for treating erectile dysfunction.
局部 SDF-1 mRNA 纳米颗粒递送用于治疗勃起功能障碍。
基本信息
- 批准号:10608145
- 负责人:
- 金额:$ 16.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-01 至 2023-08-28
- 项目状态:已结题
- 来源:
- 关键词:AffectAgeArchitectureBiological ProductsCell NucleusCellsCharacteristicsChemicalsChronicCialisClinicalClinical ResearchCustomDataDefectDiabetes MellitusDiseaseDoseDrug InteractionsEconomicsEndocrine systemEngineeringEnvironmentErectile dysfunctionExcisionExhibitsFibrosisFormulationFrequenciesFunctional disorderGangliaGenesGoalsGrowth FactorHalf-LifeHealthHistologyHumanHypertensionIn VitroIndividualInjectionsInjuryInsertional MutagenesisKineticsLeadMalignant neoplasm of prostateMeasuresMessenger RNAModalityModelingMuscleNatural regenerationNerveNervous SystemNeuronsOralPathologyPathway interactionsPatientsPelvisPersonal SatisfactionPharmaceutical PreparationsPhysiologicalPolymersPopulationProstate Cancer therapyProstatectomyProteinsQuality of lifeRadical ProstatectomyRattusRecombinantsRegimenReporterRiskRodentSafetySmooth MuscleStromal Cell-Derived Factor 1Study modelsSystemTherapeuticTimeTissuesTransfectionTreatment EfficacyUp-RegulationUrologyVariantVascular SystemViagraclinical developmentclinically relevantcurative treatmentsdelivery vehicledesignimprovedin vivoinhibitorinjuredinterestlead candidatemRNA ExpressionmRNA deliverymalemenmultidisciplinarynanoparticlenanoparticle deliverynanopolymerneurovascularneurovascular injurynovelnucleic acid deliverypenisphosphoric diester hydrolaseplasmid DNApre-clinicalpreclinical studypreventprostate cancer modelrepairedresponsesafety studyside effectstandard of carestem cellssymptom managementsymptomatic improvement
项目摘要
PROJECT SUMMARY
About 18 million men in the U.S. are affected by erectile dysfunction (ED), and it is estimated to affect
322 million men worldwide by 2025. ED is caused by various conditions that perturb vascular, nervous and/or
hormonal systems, imposing profound negative impacts on quality of life and well-being of affected males.
Advent of oral formulations of phosphodiesterase type 5 inhibitors (e.g., Viagra®) has provided a breakthrough
in managing ED to a certain degree but are frequently ineffective due to underlying neurovascular dysfunction,
and often accompanies systemic side effects and undesired drug-drug interactions. To this end, a therapeutic
modality that can intervene the natural histology of the disease among a broader affected population is sorely
needed. We have recently discovered that human recombinant stromal cell-derived factor-1 (SDF-1) promotes
regeneration of penile vasculatures, nerves and muscles to restore erectile function in a rat model of ED. The
improvement was associated with increases in major pelvic ganglion neurons and growth factor expression,
upregulation of stem-cell associated genes and decrease in penile fibrosis. Importantly, SDF-1 targets a broad
array of repair mechanisms by acting directly on resident tissues and activating stem-cell associated repair
pathways to enhance the integrity of tissue architecture and functional response. However, protein-based
therapy requires multiple and frequent doses to meet the required therapeutic window, leading to economic
and compliance issues. This is of particular concern for SDF-1 due to its very short half-live, measured in
minutes. We thus propose here to develop mRNA-based SDF-1 therapy, with a particular focus on designing
nanoparticle-based platforms providing safety and efficient mRNA delivery to penile cells, for sustainable ED
treatment. Our interest lies in nanoparticles based on environmentally-sensitive cationic polymers that
gradually degrade in physiological environments to facilitate mRNA release, ideally in intracellular milieu, and
removal of carrier materials from body. Encouragingly, our pilot data demonstrates that at least four
nanoparticles based on our custom-synthesized polymers provide significantly enhanced reporter mRNA
expression in rodent penile tissues in vivo compared to a gold-standard polymeric delivery system. We note
that chemical variations of these polymers can further improve mRNA delivery characteristics, such as broader
tissue coverage and/or enhanced transfection efficiency. To this end, we will synthesize a panel of chemically-
distinct environmentally-sensitive polymers and extensive screen in vitro and in vivo to determine lead
candidates that provide highly efficiently and safe penile mRNA expression. The lead candidates will then be
used to package and deliver optimized SDF-1 mRNA into the injured penile tissues of a rat model of ED to
establish clinical relevance. Successful execution of the proposed studies would pave the way for clinical
development of novel mRNA-based therapy for treating patients with ED, particularly those poorly responsive
to current standard-of-care treatments.
项目摘要
在美国,大约有1800万男性受到勃起功能障碍(艾德)的影响,据估计,
到2025年,全球将有3.22亿男性。艾德是由扰乱血管、神经和/或神经系统的各种病症引起的。
荷尔蒙系统,对受影响男性的生活质量和福祉产生深远的负面影响。
磷酸二酯酶5型抑制剂口服制剂的出现(例如,Viagra®)提供了突破
在一定程度上控制艾德,但由于潜在的神经血管功能障碍而经常无效,
并且经常伴随全身副作用和不希望的药物-药物相互作用。为此,一种治疗
一种可以在更广泛的受影响人群中干预疾病的自然组织学的方式,
needed.我们最近发现,人重组基质细胞衍生因子-1(SDF-1)可促进
阴茎血管、神经和肌肉的再生以恢复ED大鼠模型的勃起功能。
改善与主要盆神经节神经元和生长因子表达的增加有关,
干细胞相关基因的上调和阴茎纤维化的减少。重要的是,SDF-1针对广泛的
通过直接作用于驻留组织并激活干细胞相关修复,
途径,以增强组织结构和功能反应的完整性。然而,基于蛋白质
治疗需要多次和频繁的剂量,以满足所需的治疗窗口,导致经济
和遵守问题。由于SDF-1的半衰期非常短,这一点尤其令人担忧,
分钟因此,我们在这里提出开发基于mRNA的SDF-1治疗,特别关注设计
基于纳米颗粒的平台为阴茎细胞提供安全有效的mRNA递送,用于可持续的艾德
治疗我们的兴趣在于基于对环境敏感的阳离子聚合物的纳米颗粒,
在生理环境中逐渐降解以促进mRNA释放,理想地在细胞内环境中,和
从身体中去除载体材料。令人鼓舞的是,我们的试点数据表明,至少有四个
基于我们定制合成的聚合物的纳米颗粒可显着增强报告mRNA
与金标准聚合物递送系统相比,在啮齿动物阴茎组织中的体内表达。我们注意到
这些聚合物的化学变化可以进一步改善mRNA递送特性,例如更广泛的
组织覆盖和/或增强的转染效率。为此,我们将合成一组化学-
独特的环境敏感聚合物和广泛的体外和体内筛选,以确定铅
提供高效和安全的阴茎mRNA表达的候选物。主要候选人将是
用于将优化的SDF-1 mRNA包装并递送到艾德大鼠模型的受损阴茎组织中,
建立临床相关性。拟议研究的成功执行将为临床研究铺平道路。
开发新的基于mRNA的治疗方法,用于治疗艾德患者,特别是那些反应差的患者
目前的标准治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Johanna Lucy Hannan其他文献
Johanna Lucy Hannan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Deconstructing and Modeling the Single Cell Architecture of the Age-Related Macular Degeneration Retina and RPE/Choroid
年龄相关性黄斑变性视网膜和 RPE/脉络膜的单细胞结构的解构和建模
- 批准号:
10450171 - 财政年份:2020
- 资助金额:
$ 16.9万 - 项目类别:
Deconstructing and Modeling the Single Cell Architecture of the Age-Related Macular Degeneration Retina and RPE/Choroid
年龄相关性黄斑变性视网膜和 RPE/脉络膜的单细胞结构的解构和建模
- 批准号:
10674702 - 财政年份:2020
- 资助金额:
$ 16.9万 - 项目类别:
Deconstructing and Modeling the Single Cell Architecture of the Age-Related Macular Degeneration Retina and RPE/Choroid
年龄相关性黄斑变性视网膜和 RPE/脉络膜的单细胞结构的解构和建模
- 批准号:
10242936 - 财政年份:2020
- 资助金额:
$ 16.9万 - 项目类别:
Deconstructing and Modeling the Single Cell Architecture of the Age-Related Macular Degeneration Retina and RPE/Choroid
年龄相关性黄斑变性视网膜和 RPE/脉络膜的单细胞结构的解构和建模
- 批准号:
10058444 - 财政年份:2020
- 资助金额:
$ 16.9万 - 项目类别:
The evolution of House Architecture in the Portuguese Estremadura from Copper- to Iron Age. The evolution of Architecture, Function and Social Significance
葡萄牙埃斯特雷马杜拉从铜器时代到铁器时代房屋建筑的演变。
- 批准号:
335673224 - 财政年份:2017
- 资助金额:
$ 16.9万 - 项目类别:
Research Grants
Elucidating the Genetic Architecture of Age-Dependent Neurodegenerative Diseases
阐明年龄依赖性神经退行性疾病的遗传结构
- 批准号:
376840 - 财政年份:2017
- 资助金额:
$ 16.9万 - 项目类别:
Fellowship Programs
Architecture and Society in an Age of Reform
改革时代的建筑与社会
- 批准号:
AH/P00993X/1 - 财政年份:2017
- 资助金额:
$ 16.9万 - 项目类别:
Research Grant
Mechanistic understanding of age-dependent genetic architecture
对年龄依赖性遗传结构的机制理解
- 批准号:
8985319 - 财政年份:2015
- 资助金额:
$ 16.9万 - 项目类别:
Mechanistic understanding of age-dependent genetic architecture
对年龄依赖性遗传结构的机制理解
- 批准号:
9753013 - 财政年份:2015
- 资助金额:
$ 16.9万 - 项目类别:
Mechanistic understanding of age-dependent genetic architecture
对年龄依赖性遗传结构的机制理解
- 批准号:
9321149 - 财政年份:2015
- 资助金额:
$ 16.9万 - 项目类别: